Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Oct;71(10):7758–7768. doi: 10.1128/jvi.71.10.7758-7768.1997

Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.

M M Georgescu 1, J Balanant 1, A Macadam 1, D Otelea 1, M Combiescu 1, A A Combiescu 1, R Crainic 1, F Delpeyroux 1
PMCID: PMC192128  PMID: 9311861

Abstract

Attenuated strains of the Sabin oral poliovirus vaccine replicate in the human gut and in rare cases cause vaccine-associated paralytic poliomyelitis (VAPP). Reversion of vaccine strains toward a pathogenic phenotype is probably one of the main causes of VAPP, a disease most frequently associated with type 3 and type 2 strains and more rarely with the type 1 (Sabin 1) strain. To identify the determinants and mechanisms of safety versus pathogenicity of the Sabin 1 strain, we characterized the genetic and phenotypic changes in six Sabin 1-derived viruses isolated from immunocompetent patients with VAPP. The genomes of these strains carried either few or numerous mutations from the original Sabin 1 genome. As assessed in transgenic mice carrying the human poliovirus receptor (PVR-Tg mice), all but one strain had lost the attenuated phenotype. Four strains presented only a moderate neurovirulent phenotype, probably due at least in part to reversions to the wild-type genotype, which were detected in the 5' noncoding region of the genome. The reversions found in most strains at nucleotide position 480, are known to be associated with an increase in neurovirulence. The construction and characterization of Sabin 1 mutants implicated a reversion at position 189, found in one strain, in the phenotypic change. The presence of 71 mutations in one neurovirulent strain suggests that a vaccine-derived strain can survive for a long time in humans. Surprisingly, none of the strains analyzed were as neurovirulent to PVR-Tg mice as was the wild-type parent of Sabin 1 (Mahoney) or a previously identified neurovirulent Sabin 1 mutant selected at a high temperature in cultured cells. Thus, in the human gut, the Sabin 1 strain does not necessarily evolve toward the genetic characteristics and high neuropathogenicity of its wild-type parent.

Full Text

The Full Text of this article is available as a PDF (281.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe S., Ota Y., Doi Y., Nomoto A., Nomura T., Chumakov K. M., Hashizume S. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus. Virology. 1995 Jun 20;210(1):160–166. doi: 10.1006/viro.1995.1327. [DOI] [PubMed] [Google Scholar]
  2. Balanant J., Guillot S., Candrea A., Delpeyroux F., Crainic R. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology. 1991 Oct;184(2):645–654. doi: 10.1016/0042-6822(91)90434-d. [DOI] [PubMed] [Google Scholar]
  3. Borzakian S., Pelletier I., Calvez V., Colbere-Garapin F. Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J Virol. 1993 May;67(5):2914–2917. doi: 10.1128/jvi.67.5.2914-2917.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bouchard M. J., Lam D. H., Racaniello V. R. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol. 1995 Aug;69(8):4972–4978. doi: 10.1128/jvi.69.8.4972-4978.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bârlean L., Avram G., Pavlov E., Cotor F. Investigation of five cases of vesicular enteroviral stomatitis with exanthema induced by coxsackie A5 virus. Rev Roum Virol. 1994 Jan-Jun;45(1-2):3–9. [PubMed] [Google Scholar]
  6. Christodoulou C., Colbere-Garapin F., Macadam A., Taffs L. F., Marsden S., Minor P., Horaud F. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol. 1990 Oct;64(10):4922–4929. doi: 10.1128/jvi.64.10.4922-4929.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chumakov K. M., Dragunsky E. M., Norwood L. P., Douthitt M. P., Ran Y., Taffs R. E., Ridge J., Levenbook I. S. Consistent selection of mutations in the 5'-untranslated region of oral poliovirus vaccine upon passaging in vitro. J Med Virol. 1994 Jan;42(1):79–85. doi: 10.1002/jmv.1890420115. [DOI] [PubMed] [Google Scholar]
  8. Colbère-Garapin F., Christodoulou C., Crainic R., Garapin A. C., Candrea A. Addition of a foreign oligopeptide to the major capsid protein of poliovirus. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8668–8672. doi: 10.1073/pnas.85.22.8668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Colston E., Racaniello V. R. Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J. 1994 Dec 15;13(24):5855–5862. doi: 10.1002/j.1460-2075.1994.tb06930.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Contreras G., Dimock K., Furesz J., Gardell C., Hazlett D., Karpinski K., McCorkle G., Wu L. Genetic characterization of Sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract. Biologicals. 1992 Mar;20(1):15–26. doi: 10.1016/s1045-1056(05)80003-x. [DOI] [PubMed] [Google Scholar]
  11. Couderc T., Delpeyroux F., Le Blay H., Blondel B. Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J Virol. 1996 Jan;70(1):305–312. doi: 10.1128/jvi.70.1.305-312.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Crainic R., Couillin P., Blondel B., Cabau N., Boué A., Horodniceanu F. Natural variation of poliovirus neutralization epitopes. Infect Immun. 1983 Sep;41(3):1217–1225. doi: 10.1128/iai.41.3.1217-1225.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dildine S. L., Semler B. L. Conservation of RNA-protein interactions among picornaviruses. J Virol. 1992 Jul;66(7):4364–4376. doi: 10.1128/jvi.66.7.4364-4376.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dildine S. L., Semler B. L. The deletion of 41 proximal nucleotides reverts a poliovirus mutant containing a temperature-sensitive lesion in the 5' noncoding region of genomic RNA. J Virol. 1989 Feb;63(2):847–862. doi: 10.1128/jvi.63.2.847-862.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dunn G., Begg N. T., Cammack N., Minor P. D. Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources. J Med Virol. 1990 Oct;32(2):92–95. doi: 10.1002/jmv.1890320205. [DOI] [PubMed] [Google Scholar]
  16. Fichot O., Girard M. An improved method for sequencing of RNA templates. Nucleic Acids Res. 1990 Oct 25;18(20):6162–6162. doi: 10.1093/nar/18.20.6162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Filman D. J., Syed R., Chow M., Macadam A. J., Minor P. D., Hogle J. M. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 1989 May;8(5):1567–1579. doi: 10.1002/j.1460-2075.1989.tb03541.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Friedrich F., Filippis A. M., Ferreira F. C., Oliveira M. J., Schatzmayr H. G., Da-Silva E. E. Poliovirus type 1 isolated from a vaccine-associated case of paralytic poliomyelitis in Brazil. Braz J Med Biol Res. 1996 Jan;29(1):15–18. [PubMed] [Google Scholar]
  19. Friedrich F., Filippis A. M., Ferreira F. C., Schatzmayr H. G., Da Silva E. E. Genomic characterization of type 1 Sabin-related polioviruses isolated in Brazil. Acta Virol. 1995 Feb;39(1):23–29. [PubMed] [Google Scholar]
  20. Furione M., Guillot S., Otelea D., Balanant J., Candrea A., Crainic R. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology. 1993 Sep;196(1):199–208. doi: 10.1006/viro.1993.1468. [DOI] [PubMed] [Google Scholar]
  21. Georgescu M. M., Delpeyroux F., Tardy-Panit M., Balanant J., Combiescu M., Combiescu A. A., Guillot S., Crainic R. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J Virol. 1994 Dec;68(12):8089–8101. doi: 10.1128/jvi.68.12.8089-8101.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Georgescu M. M., Tardy-Panit M., Guillot S., Crainic R., Delpeyroux F. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus. J Virol. 1995 Sep;69(9):5278–5286. doi: 10.1128/jvi.69.9.5278-5286.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Guillot S., Otelea D., Delpeyroux F., Crainic R. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction. Vaccine. 1994 May;12(6):503–507. doi: 10.1016/0264-410x(94)90307-7. [DOI] [PubMed] [Google Scholar]
  24. Harber J., Bernhardt G., Lu H. H., Sgro J. Y., Wimmer E. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor. Virology. 1995 Dec 20;214(2):559–570. doi: 10.1006/viro.1995.0067. [DOI] [PubMed] [Google Scholar]
  25. Hogle J. M., Chow M., Filman D. J. Three-dimensional structure of poliovirus at 2.9 A resolution. Science. 1985 Sep 27;229(4720):1358–1365. doi: 10.1126/science.2994218. [DOI] [PubMed] [Google Scholar]
  26. Horie H., Koike S., Kurata T., Sato-Yoshida Y., Ise I., Ota Y., Abe S., Hioki K., Kato H., Taya C. Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence. J Virol. 1994 Feb;68(2):681–688. doi: 10.1128/jvi.68.2.681-688.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kawamura N., Kohara M., Abe S., Komatsu T., Tago K., Arita M., Nomoto A. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol. 1989 Mar;63(3):1302–1309. doi: 10.1128/jvi.63.3.1302-1309.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kean K. M., Wychowski C., Kopecka H., Girard M. Highly infectious plasmids carrying poliovirus cDNA are capable of replication in transfected simian cells. J Virol. 1986 Aug;59(2):490–493. doi: 10.1128/jvi.59.2.490-493.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kirkegaard K. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA. J Virol. 1990 Jan;64(1):195–206. doi: 10.1128/jvi.64.1.195-206.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kohara M., Abe S., Kuge S., Semler B. L., Komatsu T., Arita M., Itoh H., Nomoto A. An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine. Virology. 1986 May;151(1):21–30. doi: 10.1016/0042-6822(86)90100-5. [DOI] [PubMed] [Google Scholar]
  31. Li J., Zhang L. B., Yoneyama T., Yoshida H., Shimizu H., Yoshii K., Hara M., Nomura T., Yoshikura H., Miyamura T. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients. Arch Virol. 1996;141(6):1047–1054. doi: 10.1007/BF01718608. [DOI] [PubMed] [Google Scholar]
  32. Lu H. H., Yang C. F., Murdin A. D., Klein M. H., Harber J. J., Kew O. M., Wimmer E. Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro. J Virol. 1994 Nov;68(11):7507–7515. doi: 10.1128/jvi.68.11.7507-7515.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lu Z., Rezapkin G. V., Douthitt M. P., Ran Y., Asher D. M., Levenbook I. S., Chumakov K. M. Limited genetic changes in the Sabin 1 strain of poliovirus occurring in the central nervous system of monkeys. J Gen Virol. 1996 Feb;77(Pt 2):273–280. doi: 10.1099/0022-1317-77-2-273. [DOI] [PubMed] [Google Scholar]
  34. Macadam A. J., Arnold C., Howlett J., John A., Marsden S., Taffs F., Reeve P., Hamada N., Wareham K., Almond J. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology. 1989 Oct;172(2):408–414. doi: 10.1016/0042-6822(89)90183-9. [DOI] [PubMed] [Google Scholar]
  35. Macadam A. J., Ferguson G., Burlison J., Stone D., Skuce R., Almond J. W., Minor P. D. Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. Virology. 1992 Aug;189(2):415–422. doi: 10.1016/0042-6822(92)90565-7. [DOI] [PubMed] [Google Scholar]
  36. Macadam A. J., Pollard S. R., Ferguson G., Dunn G., Skuce R., Almond J. W., Minor P. D. The 5' noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology. 1991 Apr;181(2):451–458. doi: 10.1016/0042-6822(91)90877-e. [DOI] [PubMed] [Google Scholar]
  37. Martin A., Benichou D., Couderc T., Hogle J. M., Wychowski C., Van der Werf S., Girard M. Use of type 1/type 2 chimeric polioviruses to study determinants of poliovirus type 1 neurovirulence in a mouse model. Virology. 1991 Feb;180(2):648–658. doi: 10.1016/0042-6822(91)90078-p. [DOI] [PubMed] [Google Scholar]
  38. McGoldrick A., Macadam A. J., Dunn G., Rowe A., Burlison J., Minor P. D., Meredith J., Evans D. J., Almond J. W. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. J Virol. 1995 Dec;69(12):7601–7605. doi: 10.1128/jvi.69.12.7601-7605.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Minor P. D. The molecular biology of poliovaccines. J Gen Virol. 1992 Dec;73(Pt 12):3065–3077. doi: 10.1099/0022-1317-73-12-3065. [DOI] [PubMed] [Google Scholar]
  40. Murdin A. D., Wimmer E. Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II. J Virol. 1989 Dec;63(12):5251–5257. doi: 10.1128/jvi.63.12.5251-5257.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Muzychenko A. R., Lipskaya GYu, Maslova S. V., Svitkin Y. V., Pilipenko E. V., Nottay B. K., Kew O. M., Agol V. I. Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications. Virus Res. 1991 Oct;21(2):111–122. doi: 10.1016/0168-1702(91)90002-d. [DOI] [PubMed] [Google Scholar]
  42. Najita L., Sarnow P. Oxidation-reduction sensitive interaction of a cellular 50-kDa protein with an RNA hairpin in the 5' noncoding region of the poliovirus genome. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5846–5850. doi: 10.1073/pnas.87.15.5846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Nakano J. H., Hatch M. H., Thieme M. L., Nottay B. Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog Med Virol. 1978;24:178–206. [PubMed] [Google Scholar]
  44. Nicholson R., Pelletier J., Le S. Y., Sonenberg N. Structural and functional analysis of the ribosome landing pad of poliovirus type 2: in vivo translation studies. J Virol. 1991 Nov;65(11):5886–5894. doi: 10.1128/jvi.65.11.5886-5894.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Nomoto A., Omata T., Toyoda H., Kuge S., Horie H., Kataoka Y., Genba Y., Nakano Y., Imura N. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A. 1982 Oct;79(19):5793–5797. doi: 10.1073/pnas.79.19.5793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Nottay B. K., Kew O. M., Hatch M. H., Heyward J. T., Obijeski J. F. Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology. 1981 Jan 30;108(2):405–423. doi: 10.1016/0042-6822(81)90448-7. [DOI] [PubMed] [Google Scholar]
  47. Omata T., Kohara M., Kuge S., Komatsu T., Abe S., Semler B. L., Kameda A., Itoh H., Arita M., Wimmer E. Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol. 1986 May;58(2):348–358. doi: 10.1128/jvi.58.2.348-358.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Otelea D., Guillot S., Furione M., Combiescu A. A., Balanant J., Candrea A., Crainic R. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses. Dev Biol Stand. 1993;78:33–38. [PubMed] [Google Scholar]
  49. Pelletier J., Kaplan G., Racaniello V. R., Sonenberg N. Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region. Mol Cell Biol. 1988 Mar;8(3):1103–1112. doi: 10.1128/mcb.8.3.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Percy N., Belsham G. J., Brangwyn J. K., Sullivan M., Stone D. M., Almond J. W. Intracellular modifications induced by poliovirus reduce the requirement for structural motifs in the 5' noncoding region of the genome involved in internal initiation of protein synthesis. J Virol. 1992 Mar;66(3):1695–1701. doi: 10.1128/jvi.66.3.1695-1701.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Pilipenko E. V., Blinov V. M., Romanova L. I., Sinyakov A. N., Maslova S. V., Agol V. I. Conserved structural domains in the 5'-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology. 1989 Feb;168(2):201–209. doi: 10.1016/0042-6822(89)90259-6. [DOI] [PubMed] [Google Scholar]
  52. Rezapkin G. V., Chumakov K. M., Lu Z., Ran Y., Dragunsky E. M., Levenbook I. S. Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology. 1994 Jul;202(1):370–378. doi: 10.1006/viro.1994.1353. [DOI] [PubMed] [Google Scholar]
  53. Rico-Hesse R., Pallansch M. A., Nottay B. K., Kew O. M. Geographic distribution of wild poliovirus type 1 genotypes. Virology. 1987 Oct;160(2):311–322. doi: 10.1016/0042-6822(87)90001-8. [DOI] [PubMed] [Google Scholar]
  54. Sabin A. B. Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis. 1985 Mar;151(3):420–436. doi: 10.1093/infdis/151.3.420. [DOI] [PubMed] [Google Scholar]
  55. Skinner M. A., Racaniello V. R., Dunn G., Cooper J., Minor P. D., Almond J. W. New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol. 1989 May 20;207(2):379–392. doi: 10.1016/0022-2836(89)90261-1. [DOI] [PubMed] [Google Scholar]
  56. Strebel P. M., Aubert-Combiescu A., Ion-Nedelcu N., Biberi-Moroeanu S., Combiescu M., Sutter R. W., Kew O. M., Pallansch M. A., Patriarca P. A., Cochi S. L. Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol. 1994 Dec 15;140(12):1111–1124. doi: 10.1093/oxfordjournals.aje.a117211. [DOI] [PubMed] [Google Scholar]
  57. Strebel P. M., Sutter R. W., Cochi S. L., Biellik R. J., Brink E. W., Kew O. M., Pallansch M. A., Orenstein W. A., Hinman A. R. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis. 1992 Feb;14(2):568–579. doi: 10.1093/clinids/14.2.568. [DOI] [PubMed] [Google Scholar]
  58. Sutter R. W., Brink E. W., Cochi S. L., Kew O. M., Orenstein W. A., Biellik R. J., Hinman A. R. A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am J Public Health. 1989 Apr;79(4):495–498. doi: 10.2105/ajph.79.4.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Tardy-Panit M., Blondel B., Martin A., Tekaia F., Horaud F., Delpeyroux F. A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J Virol. 1993 Aug;67(8):4630–4638. doi: 10.1128/jvi.67.8.4630-4638.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Wimmer E., Hellen C. U., Cao X. Genetics of poliovirus. Annu Rev Genet. 1993;27:353–436. doi: 10.1146/annurev.ge.27.120193.002033. [DOI] [PubMed] [Google Scholar]
  61. Zavate O., Avram G., Pavlov E., Burlea-Iriciuc A., Ivan A., Cotor F. Coxsackie A virus-associated herpetiform angina. Virologie. 1984 Jan-Mar;35(1):49–53. [PubMed] [Google Scholar]
  62. de la Torre J. C., Giachetti C., Semler B. L., Holland J. J. High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2531–2535. doi: 10.1073/pnas.89.7.2531. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES